Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9

Abstract

IntroductionWe explored the presence of chronic complications in subjects with newly diagnosed type 2 diabetes referred to the Verona Diabetes Clinic. Metabolic (insulin secretion and sensitivity) and clinical features associated with complications were also investigated.Research design and methodsThe comprehensive assessment of microvascular and macrovascular complications included detailed medical history, resting ECG, ultrasonography of carotid and lower limb arteries, quantitative neurological evaluation, cardiovascular autonomic tests, ophthalmoscopy, kidney function tests. Insulin sensitivity and beta-cell function were assessed by state-of-the-art techniques (insulin clamp and mathematical modeling of glucose/C-peptide curves during oral glucose tolerance test).ResultsWe examined 806 patients (median age years, two-thirds males), of whom prior clinical cardiovascular disease (CVD) was revealed in 11.2% and preclinical CVD in 7.7%. Somatic neuropathy was found in 21.2% and cardiovascular autonomic neuropathy in 18.6%. Retinopathy was observed in 4.9% (background 4.2%, proliferative 0.7%). Chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m2) was found in 8.8% and excessive albuminuria in 13.2% (microalbuminuria 11.9%, macroalbuminuria 1.3%).Isolated microvascular disease occurred in 30.8%, isolated macrovascular disease in 9.3%, a combination of both in 9.1%, any complication in 49.2% and no complications in 50.8%.Gender, age, body mass index, smoking, hemoglobin A1c and/or hypertension were independently associated with one or more complications. Insulin resistance and beta-cell dysfunction were associated with macrovascular but not microvascular disease.ConclusionsDespite a generally earlier diagnosis for an increased awareness of the disease, as many as ~50% of patients with newly diagnosed type 2 diabetes had clinical or preclinical manifestations of microvascular and/or macrovascular disease. Insulin resistance might play an independent role in macrovascular disease.Trial registration numberNCT01526720.

Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database

“…It is widely accepted that CKD is a common complication of T2DM, and diabetes is the most common cause of CKD and end-stage renal disease [9]. Furthermore, CKD often develops in the early stages of T2DM [10][11][12][13]. Our data provide further evidence that CKD is a common, early comorbidity in patients with T2DM, and was more frequent in this An epidemiological link between diabetes and development of HF is evident even in the absence of ASCVD.…”

A novel diabetes typology: towards precision diabetology from pathogenesis to treatment

“…The VNDS enrols people with type 2 diabetes within 6 months of their diagnosis. Assessment of diabetes-related complications indicated a high variability in their presentation and progression [15,18]; the prevalence of one or more diabetes-related complications (CVD, nephropathy, DSPN, CAN, retinopathy) already present at study enrolment was found to be 49.2% [9].…”

“…However, this pathophysiological heterogeneity is not captured by current position statements and guidelines for diagnosis and treatment of diabetes [7,8]. Differences in risk factors and pathophysiological mechanisms are thought to drive the heterogeneity in preclinical abnormalities, prevalence of comorbidities and clinical complications already seen at diagnosis of diabetes [5,9]. People with diabetes further vary in the progression of their disease and in the incidence of diabetes-related complications despite comparable glycaemic control.…”

Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade

“…Type 2 diabetes, until recently considered mainly as a disease of elderly age, is now responsible for approximately 4-5% of premature deaths ( 7 ). Approximately 50% of people with diabetes signs delayed end-organ/system damages and as many as 40% of subjects have vascular complications, both result from the silent progression of the disease before its diagnosis ( 8 ). Hyperlipidemia (elevated blood lipid/lipoprotein levels) also severely affects various age groups in wealthy Western societies.…”